Global Colorectal Cancer Drugs Market Insights and Forecast to 2028

  • Report ID:238270
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Jun-22
  • No. of Pages: 114
                              
Colorectal Cancer Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Vascular Endothelial Growth Factor (VEGF) Inhibitors Epidermal Growth Factor Receptor (EGFR) Inhibitors Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors BRAF or MEK Inhibitors Tyrosine Kinase (TKI) Inhibitors Immunomodulators Segment by Application Radiotherapy Chemotherapy By Company AB Science Amgen Array BioPharma Bayer Boehringer Ingelheim Bristol-Myers Squibb Elli Lilly Roch Hutchison MediPharma Merck & Co., Inc. Mologen Regeneron Sanofi Sumitomo Dainippon Taiho Pharmaceutical Vaccinogen By Region North America United States Canada Mexico Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E
                        
1 Study Coverage 1.1 Colorectal Cancer Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors 1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors 1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors 1.2.5 BRAF or MEK Inhibitors 1.2.6 Tyrosine Kinase (TKI) Inhibitors 1.2.7 Immunomodulators 1.3 Market by Application 1.3.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Radiotherapy 1.3.3 Chemotherapy 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Colorectal Cancer Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Colorectal Cancer Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Colorectal Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Colorectal Cancer Drugs Sales by Region 2.4.1 Global Colorectal Cancer Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Colorectal Cancer Drugs by Region (2023-2028) 2.5 Global Colorectal Cancer Drugs Revenue by Region 2.5.1 Global Colorectal Cancer Drugs Revenue by Region (2017-2022) 2.5.2 Global Colorectal Cancer Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Colorectal Cancer Drugs Sales by Manufacturers 3.1.1 Global Top Colorectal Cancer Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Colorectal Cancer Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Colorectal Cancer Drugs in 2021 3.2 Global Colorectal Cancer Drugs Revenue by Manufacturers 3.2.1 Global Colorectal Cancer Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Colorectal Cancer Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Colorectal Cancer Drugs Revenue in 2021 3.3 Global Colorectal Cancer Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Colorectal Cancer Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Colorectal Cancer Drugs Sales by Type 4.1.1 Global Colorectal Cancer Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Colorectal Cancer Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) 4.2 Global Colorectal Cancer Drugs Revenue by Type 4.2.1 Global Colorectal Cancer Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Colorectal Cancer Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Colorectal Cancer Drugs Price by Type 4.3.1 Global Colorectal Cancer Drugs Price by Type (2017-2022) 4.3.2 Global Colorectal Cancer Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Colorectal Cancer Drugs Sales by Application 5.1.1 Global Colorectal Cancer Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Colorectal Cancer Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) 5.2 Global Colorectal Cancer Drugs Revenue by Application 5.2.1 Global Colorectal Cancer Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Colorectal Cancer Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Colorectal Cancer Drugs Price by Application 5.3.1 Global Colorectal Cancer Drugs Price by Application (2017-2022) 5.3.2 Global Colorectal Cancer Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Colorectal Cancer Drugs Market Size by Type 6.1.1 North America Colorectal Cancer Drugs Sales by Type (2017-2028) 6.1.2 North America Colorectal Cancer Drugs Revenue by Type (2017-2028) 6.2 North America Colorectal Cancer Drugs Market Size by Application 6.2.1 North America Colorectal Cancer Drugs Sales by Application (2017-2028) 6.2.2 North America Colorectal Cancer Drugs Revenue by Application (2017-2028) 6.3 North America Colorectal Cancer Drugs Market Size by Country 6.3.1 North America Colorectal Cancer Drugs Sales by Country (2017-2028) 6.3.2 North America Colorectal Cancer Drugs Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 6.3.5 Mexico 7 Europe 7.1 Europe Colorectal Cancer Drugs Market Size by Type 7.1.1 Europe Colorectal Cancer Drugs Sales by Type (2017-2028) 7.1.2 Europe Colorectal Cancer Drugs Revenue by Type (2017-2028) 7.2 Europe Colorectal Cancer Drugs Market Size by Application 7.2.1 Europe Colorectal Cancer Drugs Sales by Application (2017-2028) 7.2.2 Europe Colorectal Cancer Drugs Revenue by Application (2017-2028) 7.3 Europe Colorectal Cancer Drugs Market Size by Country 7.3.1 Europe Colorectal Cancer Drugs Sales by Country (2017-2028) 7.3.2 Europe Colorectal Cancer Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Colorectal Cancer Drugs Market Size by Type 8.1.1 Asia Pacific Colorectal Cancer Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Colorectal Cancer Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Colorectal Cancer Drugs Market Size by Application 8.2.1 Asia Pacific Colorectal Cancer Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Colorectal Cancer Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Colorectal Cancer Drugs Market Size by Region 8.3.1 Asia Pacific Colorectal Cancer Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Colorectal Cancer Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Colorectal Cancer Drugs Market Size by Type 9.1.1 Latin America Colorectal Cancer Drugs Sales by Type (2017-2028) 9.1.2 Latin America Colorectal Cancer Drugs Revenue by Type (2017-2028) 9.2 Latin America Colorectal Cancer Drugs Market Size by Application 9.2.1 Latin America Colorectal Cancer Drugs Sales by Application (2017-2028) 9.2.2 Latin America Colorectal Cancer Drugs Revenue by Application (2017-2028) 9.3 Latin America Colorectal Cancer Drugs Market Size by Country 9.3.1 Latin America Colorectal Cancer Drugs Sales by Country (2017-2028) 9.3.2 Latin America Colorectal Cancer Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Colorectal Cancer Drugs Market Size by Type 10.1.1 Middle East and Africa Colorectal Cancer Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Colorectal Cancer Drugs Market Size by Application 10.2.1 Middle East and Africa Colorectal Cancer Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Colorectal Cancer Drugs Market Size by Country 10.3.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 AB Science 11.1.1 AB Science Corporation Information 11.1.2 AB Science Overview 11.1.3 AB Science Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 AB Science Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 AB Science Recent Developments 11.2 Amgen 11.2.1 Amgen Corporation Information 11.2.2 Amgen Overview 11.2.3 Amgen Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Amgen Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Amgen Recent Developments 11.3 Array BioPharma 11.3.1 Array BioPharma Corporation Information 11.3.2 Array BioPharma Overview 11.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Array BioPharma Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Array BioPharma Recent Developments 11.4 Bayer 11.4.1 Bayer Corporation Information 11.4.2 Bayer Overview 11.4.3 Bayer Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Bayer Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Bayer Recent Developments 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Corporation Information 11.5.2 Boehringer Ingelheim Overview 11.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Boehringer Ingelheim Recent Developments 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Corporation Information 11.6.2 Bristol-Myers Squibb Overview 11.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bristol-Myers Squibb Recent Developments 11.7 Elli Lilly 11.7.1 Elli Lilly Corporation Information 11.7.2 Elli Lilly Overview 11.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Elli Lilly Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Elli Lilly Recent Developments 11.8 Roch 11.8.1 Roch Corporation Information 11.8.2 Roch Overview 11.8.3 Roch Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Roch Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Roch Recent Developments 11.9 Hutchison MediPharma 11.9.1 Hutchison MediPharma Corporation Information 11.9.2 Hutchison MediPharma Overview 11.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Hutchison MediPharma Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Hutchison MediPharma Recent Developments 11.10 Merck & Co., Inc. 11.10.1 Merck & Co., Inc. Corporation Information 11.10.2 Merck & Co., Inc. Overview 11.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Merck & Co., Inc. Recent Developments 11.11 Mologen 11.11.1 Mologen Corporation Information 11.11.2 Mologen Overview 11.11.3 Mologen Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Mologen Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Mologen Recent Developments 11.12 Regeneron 11.12.1 Regeneron Corporation Information 11.12.2 Regeneron Overview 11.12.3 Regeneron Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Regeneron Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Regeneron Recent Developments 11.13 Sanofi 11.13.1 Sanofi Corporation Information 11.13.2 Sanofi Overview 11.13.3 Sanofi Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Sanofi Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Sanofi Recent Developments 11.14 Sumitomo Dainippon 11.14.1 Sumitomo Dainippon Corporation Information 11.14.2 Sumitomo Dainippon Overview 11.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Sumitomo Dainippon Recent Developments 11.15 Taiho Pharmaceutical 11.15.1 Taiho Pharmaceutical Corporation Information 11.15.2 Taiho Pharmaceutical Overview 11.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Taiho Pharmaceutical Recent Developments 11.16 Vaccinogen 11.16.1 Vaccinogen Corporation Information 11.16.2 Vaccinogen Overview 11.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Vaccinogen Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Vaccinogen Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Colorectal Cancer Drugs Industry Chain Analysis 12.2 Colorectal Cancer Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Colorectal Cancer Drugs Production Mode & Process 12.4 Colorectal Cancer Drugs Sales and Marketing 12.4.1 Colorectal Cancer Drugs Sales Channels 12.4.2 Colorectal Cancer Drugs Distributors 12.5 Colorectal Cancer Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Colorectal Cancer Drugs Industry Trends 13.2 Colorectal Cancer Drugs Market Drivers 13.3 Colorectal Cancer Drugs Market Challenges 13.4 Colorectal Cancer Drugs Market Restraints 14 Key Findings in The Global Colorectal Cancer Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
                
List of Tables Table 1. Global Colorectal Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Vascular Endothelial Growth Factor (VEGF) Inhibitors Table 3. Major Manufacturers of Epidermal Growth Factor Receptor (EGFR) Inhibitors Table 4. Major Manufacturers of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Table 5. Major Manufacturers of BRAF or MEK Inhibitors Table 6. Major Manufacturers of Tyrosine Kinase (TKI) Inhibitors Table 7. Major Manufacturers of Immunomodulators Table 8. Global Colorectal Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Colorectal Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 10. Global Colorectal Cancer Drugs Sales by Region (2017-2022) & (MT) Table 11. Global Colorectal Cancer Drugs Sales Market Share by Region (2017-2022) Table 12. Global Colorectal Cancer Drugs Sales by Region (2023-2028) & (MT) Table 13. Global Colorectal Cancer Drugs Sales Market Share by Region (2023-2028) Table 14. Global Colorectal Cancer Drugs Revenue by Region (2017-2022) & (US$ Million) Table 15. Global Colorectal Cancer Drugs Revenue Market Share by Region (2017-2022) Table 16. Global Colorectal Cancer Drugs Revenue by Region (2023-2028) & (US$ Million) Table 17. Global Colorectal Cancer Drugs Revenue Market Share by Region (2023-2028) Table 18. Global Colorectal Cancer Drugs Sales by Manufacturers (2017-2022) & (MT) Table 19. Global Colorectal Cancer Drugs Sales Share by Manufacturers (2017-2022) Table 20. Global Colorectal Cancer Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 21. Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2017-2022) Table 22. Colorectal Cancer Drugs Price by Manufacturers (2017-2022) &(USD/Kg) Table 23. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 24. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2021) Table 25. Colorectal Cancer Drugs Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Colorectal Cancer Drugs Product Offered Table 27. Date of Manufacturers Enter into Colorectal Cancer Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Colorectal Cancer Drugs Sales by Type (2017-2022) & (MT) Table 30. Global Colorectal Cancer Drugs Sales by Type (2023-2028) & (MT) Table 31. Global Colorectal Cancer Drugs Sales Share by Type (2017-2022) Table 32. Global Colorectal Cancer Drugs Sales Share by Type (2023-2028) Table 33. Global Colorectal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million) Table 34. Global Colorectal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million) Table 35. Global Colorectal Cancer Drugs Revenue Share by Type (2017-2022) Table 36. Global Colorectal Cancer Drugs Revenue Share by Type (2023-2028) Table 37. Colorectal Cancer Drugs Price by Type (2017-2022) & (USD/Kg) Table 38. Global Colorectal Cancer Drugs Price Forecast by Type (2023-2028) & (USD/Kg) Table 39. Global Colorectal Cancer Drugs Sales by Application (2017-2022) & (MT) Table 40. Global Colorectal Cancer Drugs Sales by Application (2023-2028) & (MT) Table 41. Global Colorectal Cancer Drugs Sales Share by Application (2017-2022) Table 42. Global Colorectal Cancer Drugs Sales Share by Application (2023-2028) Table 43. Global Colorectal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million) Table 44. Global Colorectal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million) Table 45. Global Colorectal Cancer Drugs Revenue Share by Application (2017-2022) Table 46. Global Colorectal Cancer Drugs Revenue Share by Application (2023-2028) Table 47. Colorectal Cancer Drugs Price by Application (2017-2022) & (USD/Kg) Table 48. Global Colorectal Cancer Drugs Price Forecast by Application (2023-2028) & (USD/Kg) Table 49. North America Colorectal Cancer Drugs Sales by Type (2017-2022) & (MT) Table 50. North America Colorectal Cancer Drugs Sales by Type (2023-2028) & (MT) Table 51. North America Colorectal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million) Table 52. North America Colorectal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million) Table 53. North America Colorectal Cancer Drugs Sales by Application (2017-2022) & (MT) Table 54. North America Colorectal Cancer Drugs Sales by Application (2023-2028) & (MT) Table 55. North America Colorectal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million) Table 56. North America Colorectal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million) Table 57. North America Colorectal Cancer Drugs Sales by Country (2017-2022) & (MT) Table 58. North America Colorectal Cancer Drugs Sales by Country (2023-2028) & (MT) Table 59. North America Colorectal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million) Table 60. North America Colorectal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million) Table 61. Europe Colorectal Cancer Drugs Sales by Type (2017-2022) & (MT) Table 62. Europe Colorectal Cancer Drugs Sales by Type (2023-2028) & (MT) Table 63. Europe Colorectal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million) Table 64. Europe Colorectal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million) Table 65. Europe Colorectal Cancer Drugs Sales by Application (2017-2022) & (MT) Table 66. Europe Colorectal Cancer Drugs Sales by Application (2023-2028) & (MT) Table 67. Europe Colorectal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million) Table 68. Europe Colorectal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million) Table 69. Europe Colorectal Cancer Drugs Sales by Country (2017-2022) & (MT) Table 70. Europe Colorectal Cancer Drugs Sales by Country (2023-2028) & (MT) Table 71. Europe Colorectal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million) Table 72. Europe Colorectal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million) Table 73. Asia Pacific Colorectal Cancer Drugs Sales by Type (2017-2022) & (MT) Table 74. Asia Pacific Colorectal Cancer Drugs Sales by Type (2023-2028) & (MT) Table 75. Asia Pacific Colorectal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million) Table 76. Asia Pacific Colorectal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million) Table 77. Asia Pacific Colorectal Cancer Drugs Sales by Application (2017-2022) & (MT) Table 78. Asia Pacific Colorectal Cancer Drugs Sales by Application (2023-2028) & (MT) Table 79. Asia Pacific Colorectal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million) Table 80. Asia Pacific Colorectal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million) Table 81. Asia Pacific Colorectal Cancer Drugs Sales by Region (2017-2022) & (MT) Table 82. Asia Pacific Colorectal Cancer Drugs Sales by Region (2023-2028) & (MT) Table 83. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2017-2022) & (US$ Million) Table 84. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2023-2028) & (US$ Million) Table 85. Latin America Colorectal Cancer Drugs Sales by Type (2017-2022) & (MT) Table 86. Latin America Colorectal Cancer Drugs Sales by Type (2023-2028) & (MT) Table 87. Latin America Colorectal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million) Table 88. Latin America Colorectal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million) Table 89. Latin America Colorectal Cancer Drugs Sales by Application (2017-2022) & (MT) Table 90. Latin America Colorectal Cancer Drugs Sales by Application (2023-2028) & (MT) Table 91. Latin America Colorectal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million) Table 92. Latin America Colorectal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million) Table 93. Latin America Colorectal Cancer Drugs Sales by Country (2017-2022) & (MT) Table 94. Latin America Colorectal Cancer Drugs Sales by Country (2023-2028) & (MT) Table 95. Latin America Colorectal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million) Table 96. Latin America Colorectal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million) Table 97. Middle East and Africa Colorectal Cancer Drugs Sales by Type (2017-2022) & (MT) Table 98. Middle East and Africa Colorectal Cancer Drugs Sales by Type (2023-2028) & (MT) Table 99. Middle East and Africa Colorectal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million) Table 100. Middle East and Africa Colorectal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million) Table 101. Middle East and Africa Colorectal Cancer Drugs Sales by Application (2017-2022) & (MT) Table 102. Middle East and Africa Colorectal Cancer Drugs Sales by Application (2023-2028) & (MT) Table 103. Middle East and Africa Colorectal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million) Table 104. Middle East and Africa Colorectal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million) Table 105. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2017-2022) & (MT) Table 106. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2023-2028) & (MT) Table 107. Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million) Table 108. Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million) Table 109. AB Science Corporation Information Table 110. AB Science Description and Major Businesses Table 111. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 112. AB Science Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 113. AB Science Recent Developments Table 114. Amgen Corporation Information Table 115. Amgen Description and Major Businesses Table 116. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 117. Amgen Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 118. Amgen Recent Developments Table 119. Array BioPharma Corporation Information Table 120. Array BioPharma Description and Major Businesses Table 121. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 122. Array BioPharma Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 123. Array BioPharma Recent Developments Table 124. Bayer Corporation Information Table 125. Bayer Description and Major Businesses Table 126. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 127. Bayer Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 128. Bayer Recent Developments Table 129. Boehringer Ingelheim Corporation Information Table 130. Boehringer Ingelheim Description and Major Businesses Table 131. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 132. Boehringer Ingelheim Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 133. Boehringer Ingelheim Recent Developments Table 134. Bristol-Myers Squibb Corporation Information Table 135. Bristol-Myers Squibb Description and Major Businesses Table 136. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 137. Bristol-Myers Squibb Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 138. Bristol-Myers Squibb Recent Developments Table 139. Elli Lilly Corporation Information Table 140. Elli Lilly Description and Major Businesses Table 141. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 142. Elli Lilly Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 143. Elli Lilly Recent Developments Table 144. Roch Corporation Information Table 145. Roch Description and Major Businesses Table 146. Roch Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 147. Roch Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 148. Roch Recent Developments Table 149. Hutchison MediPharma Corporation Information Table 150. Hutchison MediPharma Description and Major Businesses Table 151. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 152. Hutchison MediPharma Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 153. Hutchison MediPharma Recent Developments Table 154. Merck & Co., Inc. Corporation Information Table 155. Merck & Co., Inc. Description and Major Businesses Table 156. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 157. Merck & Co., Inc. Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 158. Merck & Co., Inc. Recent Developments Table 159. Mologen Corporation Information Table 160. Mologen Description and Major Businesses Table 161. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 162. Mologen Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 163. Mologen Recent Developments Table 164. Regeneron Corporation Information Table 165. Regeneron Description and Major Businesses Table 166. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 167. Regeneron Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 168. Regeneron Recent Developments Table 169. Sanofi Corporation Information Table 170. Sanofi Description and Major Businesses Table 171. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 172. Sanofi Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 173. Sanofi Recent Developments Table 174. Sumitomo Dainippon Corporation Information Table 175. Sumitomo Dainippon Description and Major Businesses Table 176. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 177. Sumitomo Dainippon Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 178. Sumitomo Dainippon Recent Developments Table 179. Taiho Pharmaceutical Corporation Information Table 180. Taiho Pharmaceutical Description and Major Businesses Table 181. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 182. Taiho Pharmaceutical Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 183. Taiho Pharmaceutical Recent Developments Table 184. Vaccinogen Corporation Information Table 185. Vaccinogen Description and Major Businesses Table 186. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 187. Vaccinogen Colorectal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 188. Vaccinogen Recent Developments Table 189. Key Raw Materials Lists Table 190. Raw Materials Key Suppliers Lists Table 191. Colorectal Cancer Drugs Distributors List Table 192. Colorectal Cancer Drugs Customers List Table 193. Colorectal Cancer Drugs Market Trends Table 194. Colorectal Cancer Drugs Market Drivers Table 195. Colorectal Cancer Drugs Market Challenges Table 196. Colorectal Cancer Drugs Market Restraints Table 197. Research Programs/Design for This Report Table 198. Key Data Information from Secondary Sources Table 199. Key Data Information from Primary Sources List of Figures Figure 1. Colorectal Cancer Drugs Product Picture Figure 3. Global Colorectal Cancer Drugs Market Share by Type in 2021 & 2028 Figure 3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture Figure 4. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture Figure 5. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture Figure 6. BRAF or MEK Inhibitors Product Picture Figure 7. Tyrosine Kinase (TKI) Inhibitors Product Picture Figure 8. Immunomodulators Product Picture Figure 9. Global Colorectal Cancer Drugs Market Share by Application in 2021 & 2028 Figure 10. Radiotherapy Figure 11. Chemotherapy Figure 12. Colorectal Cancer Drugs Report Years Considered Figure 13. Global Colorectal Cancer Drugs Sales 2017-2028 (MT) Figure 14. Global Colorectal Cancer Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Colorectal Cancer Drugs Revenue 2017-2028 (US$ Million) Figure 16. Global Colorectal Cancer Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 17. Global Colorectal Cancer Drugs Sales Market Share by Region (2017-2022) Figure 18. Global Colorectal Cancer Drugs Sales Market Share by Region (2023-2028) Figure 19. North America Colorectal Cancer Drugs Sales YoY (2017-2028) & (MT) Figure 20. North America Colorectal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 21. Europe Colorectal Cancer Drugs Sales YoY (2017-2028) & (MT) Figure 22. Europe Colorectal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 23. Asia-Pacific Colorectal Cancer Drugs Sales YoY (2017-2028) & (MT) Figure 24. Asia-Pacific Colorectal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 25. Latin America Colorectal Cancer Drugs Sales YoY (2017-2028) & (MT) Figure 26. Latin America Colorectal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 27. Middle East & Africa Colorectal Cancer Drugs Sales YoY (2017-2028) & (MT) Figure 28. Middle East & Africa Colorectal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 29. The Colorectal Cancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 30. The Top 5 and 10 Largest Manufacturers of Colorectal Cancer Drugs in the World: Market Share by Colorectal Cancer Drugs Revenue in 2021 Figure 31. Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 32. Global Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) Figure 33. Global Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) Figure 34. Global Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) Figure 35. Global Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) Figure 36. North America Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) Figure 37. North America Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) Figure 38. North America Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) Figure 39. North America Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) Figure 40. North America Colorectal Cancer Drugs Sales Share by Country (2017-2028) Figure 41. North America Colorectal Cancer Drugs Revenue Share by Country (2017-2028) Figure 42. United States Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 43. Canada Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 44. Mexico Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 45. Europe Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) Figure 46. Europe Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) Figure 47. Europe Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) Figure 48. Europe Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) Figure 49. Europe Colorectal Cancer Drugs Sales Share by Country (2017-2028) Figure 50. Europe Colorectal Cancer Drugs Revenue Share by Country (2017-2028) Figure 51. Germany Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 52. France Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 53. U.K. Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 54. Italy Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 55. Russia Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 56. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) Figure 57. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) Figure 58. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) Figure 59. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) Figure 60. Asia Pacific Colorectal Cancer Drugs Sales Share by Region (2017-2028) Figure 61. Asia Pacific Colorectal Cancer Drugs Revenue Share by Region (2017-2028) Figure 62. China Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 63. Japan Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 64. South Korea Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 65. India Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 66. Australia Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 67. Taiwan Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 68. Indonesia Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 69. Thailand Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 70. Malaysia Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 71. Philippines Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 72. Latin America Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) Figure 73. Latin America Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) Figure 74. Latin America Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) Figure 75. Latin America Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) Figure 76. Latin America Colorectal Cancer Drugs Sales Share by Country (2017-2028) Figure 77. Latin America Colorectal Cancer Drugs Revenue Share by Country (2017-2028) Figure 78. Mexico Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 79. Brazil Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 80. Argentina Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 81. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Type (2017-2028) Figure 82. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Type (2017-2028) Figure 83. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Application (2017-2028) Figure 84. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Application (2017-2028) Figure 85. Middle East and Africa Colorectal Cancer Drugs Sales Share by Country (2017-2028) Figure 86. Middle East and Africa Colorectal Cancer Drugs Revenue Share by Country (2017-2028) Figure 87. Turkey Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 88. Saudi Arabia Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 89. U.A.E Colorectal Cancer Drugs Revenue (2017-2028) & (US$ Million) Figure 90. Colorectal Cancer Drugs Value Chain Figure 91. Colorectal Cancer Drugs Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.